These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 1747716

  • 21. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S, Kitagawa M, Morimoto S, Miyazaki Y, Minakata S, Yasukawa S, Fukatani T, Ohkawa T.
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [Abstract] [Full Text] [Related]

  • 22. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W, Kochakarn W, Ruangraksa C, Domrongkitchaiporn S.
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [Abstract] [Full Text] [Related]

  • 23. Possible link between vitamin D and hyperoxaluria in patients with renal stone disease.
    Giannini S, Nobile M, Castrignano R, Pati T, Tasca A, Villi G, Pellegrini F, D'Angelo A.
    Clin Sci (Lond); 1993 Jan; 84(1):51-4. PubMed ID: 8382134
    [Abstract] [Full Text] [Related]

  • 24. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
    Brown JM, Stratmann G, Cowley DM, Mottram BM, Chalmers AH.
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
    [Abstract] [Full Text] [Related]

  • 25. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.
    Seeger H, Kaelin A, Ferraro PM, Weber D, Jaeger P, Ambuehl P, Robertson WG, Unwin R, Wagner CA, Mohebbi N.
    BMC Nephrol; 2017 Dec 04; 18(1):349. PubMed ID: 29202723
    [Abstract] [Full Text] [Related]

  • 26. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
    Bamberger JN, Blum KA, Kan KM, Parkhomenko E, Gallante B, Gupta M.
    J Endourol; 2019 Sep 04; 33(9):755-760. PubMed ID: 31154910
    [Abstract] [Full Text] [Related]

  • 27. Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones.
    Mitwalli A, Ayiomamitis A, Grass L, Oreopoulos DG.
    Int Urol Nephrol; 1988 Sep 04; 20(4):353-9. PubMed ID: 3170105
    [Abstract] [Full Text] [Related]

  • 28. Effect of high-calcium diet on urinary oxalate excretion in urinary stone formers.
    Nakada T, Sasagawa I, Furuta H, Katayama T, Shimazaki J.
    Eur Urol; 1988 Sep 04; 15(3-4):264-70. PubMed ID: 3215261
    [Abstract] [Full Text] [Related]

  • 29. Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects.
    Lindsjö M, Danielson BG, Fellström B, Ljunghall S.
    Scand J Urol Nephrol; 1989 Sep 04; 23(1):55-9. PubMed ID: 2922580
    [Abstract] [Full Text] [Related]

  • 30. Enteric and mild hyperoxaluria.
    Sutton RA, Walker VR.
    Miner Electrolyte Metab; 1994 Sep 04; 20(6):352-60. PubMed ID: 7783697
    [Abstract] [Full Text] [Related]

  • 31. Effect of dietary intake on urinary oxalate excretion in calcium oxalate stone formers in their forties.
    Naya Y, Ito H, Masai M, Yamaguchi K.
    Eur Urol; 2000 Feb 04; 37(2):140-4. PubMed ID: 10705190
    [Abstract] [Full Text] [Related]

  • 32. Future treatments for hyperoxaluria.
    Burns Z, Knight J, Fargue S, Holmes R, Assimos D, Wood K.
    Curr Opin Urol; 2020 Mar 04; 30(2):171-176. PubMed ID: 31895888
    [Abstract] [Full Text] [Related]

  • 33. Comparison of renal function and metabolic abnormalities of cystine stone patients and calcium oxalate stone patients in China.
    Shen L, Sun X, Zhu H, Cong X, Ning B.
    World J Urol; 2013 Oct 04; 31(5):1219-23. PubMed ID: 22622395
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L, Meschi T, Guerra A, Bergamaschi E, Mutti A, Novarini A.
    Clin Chim Acta; 1995 Jul 31; 239(1):1-11. PubMed ID: 7586581
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
    Rodgers AL, Allie-Hamdulay S, Jackson GE, Sutton RA.
    J Endourol; 2014 Aug 31; 28(8):985-94. PubMed ID: 24773381
    [Abstract] [Full Text] [Related]

  • 38. Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation.
    Mikami K, Akakura K, Takei K, Ueda T, Mizoguchi K, Noda M, Miyake M, Ito H.
    Int J Urol; 2003 Jun 31; 10(6):293-6. PubMed ID: 12757596
    [Abstract] [Full Text] [Related]

  • 39. Diet and hyperoxaluria in the syndrome of idiopathic calcium oxalate urolithiasis.
    Smith LH.
    Am J Kidney Dis; 1991 Apr 31; 17(4):370-5. PubMed ID: 2008901
    [Abstract] [Full Text] [Related]

  • 40. Prospective Randomized Evaluation of Idiopathic Hyperoxaluria Treatments.
    Gupta M, Gallante B, Bamberger JN, Khusid JA, Parkhomenko E, Chandhoke R, Capodice J, Atallah W.
    J Endourol; 2021 Dec 31; 35(12):1844-1851. PubMed ID: 34254834
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.